Annual Cash & Cash Equivalents
$448.35M$223.95M-33.31%
Summary
- Current Value
- As of today, GDRX annual cash & cash equivalents is $448.35M, down -33.31% on
- Historical Performance
- GDRX annual cash & cash equivalents is down -52.36% over the past 3 years, and up +1621.10% over the past 5 years
- All-Time High Comparison
- GDRX annual cash & cash equivalents is currently -53.85% below its historical high of $971.59M set on
- 3-Year Low Comparison
- GDRX annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- GDRX annual cash & cash equivalents is higher than 88.15% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $448.35M | -33.3% | -52.4% | +1621.1% | +1798.7% | |
| Quarterly Cash & Cash Equivalents | $273.53M | -35.5% | -62.5% | -74.6% | – | |
| Price | $2.85 | -35.4% | -41.1% | -93.2% | – | |
| Annual Current Assets | $659.26M | -24.5% | -39.5% | +661.4% | +100.0% | |
| Annual Total Liabilities | $663.41M | -19.8% | -18.3% | -11.8% | +1339.7% | |
| Annual Working Capital | $535.35M | -28.6% | -46.9% | +906.1% | +100.0% | |
| Annual Net Income | $16.39M | +284.8% | +164.9% | -61.4% | +310.8% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $757.17M | N/A | -40.8% |
| 5Y | $971.59M | N/A | -53.9% |
| All | $971.59M | -53.9% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $448.35M | at low | |
| 5Y | $448.35M | at low | |
| All | $17.54M | +2456.3% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $448.35M | -33.3% | |
| $672.30M | -11.2% | |
| $757.17M | -19.5% | |
| $941.11M | -3.1% | |
| $971.59M | +3,629.7% |
| Year | Value | Change |
|---|---|---|
| $26.05M | -24.7% | |
| $34.60M | +97.3% | |
| $17.54M | -25.7% | |
| $23.61M | - |
FAQ
What is the current annual cash & cash equivalents of GDRX?
As of today, GDRX annual cash & cash equivalents is $448.35M
What is 1-year change in GDRX annual cash & cash equivalents?
GDRX annual cash & cash equivalents is down -33.31% year-over-year
What is 3-year change in GDRX annual cash & cash equivalents?
GDRX annual cash & cash equivalents is down -52.36% over the past 3 years
How far is GDRX annual cash & cash equivalents from its all-time high?
GDRX annual cash & cash equivalents is currently -53.85% below its historical high of $971.59M set on December 31, 2020
How does GDRX annual cash & cash equivalents rank versus sector peers?
GDRX annual cash & cash equivalents is higher than 88.15% of companies in Healthcare sector
When is GDRX next annual earnings release?
The next annual earnings release for GDRX is on
Quarterly Cash & Cash Equivalents
$273.53M$7.79M-2.77%
Summary
- Current Value
- As of today, GDRX quarterly cash & cash equivalents is $273.53M, down -2.77% on
- Historical Performance
- GDRX quarterly cash & cash equivalents is down -35.45% year-over-year, and down -62.47% over the past 3 years
- All-Time High Comparison
- GDRX quarterly cash & cash equivalents is currently -74.62% below its historical high of $1.08B set on
- 3-Year Low Comparison
- GDRX quarterly cash & cash equivalents is at its 3-year low
- Sector Comparison
- GDRX quarterly cash & cash equivalents is higher than 75.28% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $273.53M | -2.8% | -35.5% | -62.5% | -74.6% | |
| Annual Cash & Cash Equivalents | $448.35M | – | -33.3% | -52.4% | +1621.1% | |
| Price | $2.85 | -35.1% | -35.4% | -41.1% | -93.2% | |
| Quarterly Current Assets | $565.52M | +2.7% | -9.8% | -35.6% | -52.1% | |
| Quarterly Total Liabilities | $724.80M | +7.3% | +10.1% | -6.9% | -8.3% | |
| Quarterly Working Capital | $383.66M | -8.6% | -25.1% | -51.6% | -65.8% | |
| Quarterly Net Income | $1.12M | -91.3% | -71.8% | +102.7% | +102.2% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $448.35M | N/A | -39.0% |
| 3Y | $794.91M | -65.6% | |
| 5Y | $993.36M | -72.5% | |
| All | $1.08B | -74.6% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $273.53M | at low | |
| 3Y | $273.53M | at low | |
| 5Y | $273.53M | at low | |
| All | $26.05M | +950.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of GDRX?
As of today, GDRX quarterly cash & cash equivalents is $273.53M
What is GDRX quarterly cash & cash equivalents most recent change?
GDRX quarterly cash & cash equivalents was down -2.77% on September 30, 2025
What is 1-year change in GDRX quarterly cash & cash equivalents?
GDRX quarterly cash & cash equivalents is down -35.45% year-over-year
How far is GDRX quarterly cash & cash equivalents from its all-time high?
GDRX quarterly cash & cash equivalents is currently -74.62% below its historical high of $1.08B set on September 30, 2020
How does GDRX quarterly cash & cash equivalents rank versus sector peers?
GDRX quarterly cash & cash equivalents is higher than 75.28% of companies in Healthcare sector
When is GDRX next earnings release?
The next earnings release for GDRX is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- GDRX Official Website www.goodrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1809519/000180951925000143/0001809519-25-000143-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1809519/000180951925000040/0001809519-25-000040-index.htm
- GDRX Profile on Yahoo Finance finance.yahoo.com/quote/GDRX
- GDRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gdrx